What is the current Price Target for the Equillium, Inc. stock?

The average Equillium, Inc. target price is $1.00. This is 121.63% higher than the current stock price. 1 Analyst has issued a Equillium, Inc. price target 2026.

How high will the Equillium, Inc. stock rise?

No reliable answer can be given as to how high the Equillium, Inc. stock will rise. The performance of stocks, including the Equillium, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Equillium, Inc. stock today?

The performance of Equillium, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Equillium, Inc. stock fall?

The decline in Equillium, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Equillium, Inc. Forecast, price target & analysts

$0.45

4.55% yesterday

Nasdaq, Apr 07, 10:00 pm CET

ISIN

US29446K1060

Symbol

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Equillium, Inc. Target price 2025 - Analyst rating & recommendation

Equillium, Inc. Classifications & Recommendation:

Hold

100%

Equillium, Inc. Price Target

Target Price	$1.00
Price	$0.45
Potential	121.63% register free of charge
Number of Estimates	1

	1 Analyst has issued a Equillium, Inc. price target 2026. The average Equillium, Inc. target price is $1.00. This is 121.63% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 0 Analysts recommend Equillium, Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Equillium, Inc. stock has an average upside potential 2026 of 121.63% register free of charge . Most analysts recommend the Equillium, Inc. stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.23	-0.89
	39.47%	286.96%
P/E		negative

1 Analysts have issued a Equillium, Inc. forecast for earnings per share. The average Equillium, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.23	39.47%
2025	$-0.89 286.96% Unlock

Current	-1.98	64.32%
2025	-0.51 74.24% Unlock

Equillium, Inc....

Current Equillium, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Leerink Partners	Locked ➜ Locked	Locked	Mar 28 2025
Jones Trading	Locked ➜ Locked	Locked	Nov 01 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 19 2024

Analyst Rating	Date
Locked Leerink Partners: Locked ➜ Locked	Mar 28 2025
Locked Jones Trading: Locked ➜ Locked	Nov 01 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 19 2024

Discover more stocks with a high price target

MongoDB 96.77%

Coinbase Global, Inc. 95.22%

BioNTech SE - ADR 59.48%

Snowflake 58.39%

Alibaba Group Holding Ltd 58.36%

PayPal 58.24%

NIO ADR 57.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now